Cart
sales@molnova.com
CeMMEC2
CAS No. 902955-25-3
CeMMEC2( CeMMEC 2 )
Catalog No. M16491 CAS No. 902955-25-3
CeMMEC2 is a novel potent BRD4 inhibitor with IC50 of 0.9 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCeMMEC2
-
NoteResearch use only, not for human use.
-
Brief DescriptionCeMMEC2 is a novel potent BRD4 inhibitor with IC50 of 0.9 uM.
-
DescriptionCeMMEC2 is a novel potent BRD4 inhibitor with IC50 of 0.9 uM, binds to both bromodomains of BRD4, comparably to (S)-JQ1.
-
In Vitro——
-
In Vivo——
-
SynonymsCeMMEC 2
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBromodomain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number902955-25-3
-
Formula Weight257.34
-
Molecular FormulaC14H19N5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=NN=C2C=CC(NCCC3=CCCCC3)=NN21
-
Chemical NameN-[2-(cyclohex-1-en-1-yl)ethyl]-3-methyl[1,2,4]triazolo[4,3-b]pyridazin-6-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sdelci S, et al. Nat Chem Biol. 2016 Jul;12(7):504-10.
2. Blank, J. et al. WPO patent WO/2014/191894 (2014).
molnova catalog
related products
-
GSK4027
GSK4027 (GSK 4027, GSK-4027) is a potent, selective, cell-penetrant chemical probe of PCAF/GCN5 bromodomain with pKi of 8.9 for both.
-
PF-CBP1
A potent, highly selective CBP/p300 bromodomains inhibitor with IC50 of 125 nM and 363 nM, respectively.
-
CPI 0610
CPI 0610 is a potent, selective, and cell-active BET bromodomain inhibitor with IC50 of 39 nM for BRD4-BD1 in TR-FRET assay.
